Secukinumab does not increase IBD incidence in patients with psoriasis, spondyloarthropathies – Healio

Secukinumab does not increase IBD incidence in patients with psoriasis, spondyloarthropathies
Healio
Reports of Crohn's disease and ulcerative colitis among patients with psoriasis, psoriatic arthritis or ankylosing spondylitis treated with secukinumab were infrequent and consistent with earlier findings, according to data presented at the American ...

Read the original post:

Secukinumab does not increase IBD incidence in patients with psoriasis, spondyloarthropathies - Healio

Related Posts

Comments are closed.